Association between the T27C polymorphism in the cytochrome P450 c17? (CYP17) gene and risk factors for breast cancer
- 1 December 2004
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 88 (3) , 217-230
- https://doi.org/10.1007/s10549-004-0780-7
Abstract
Mammographic density is associated with increased breast cancer risk and is influenced by sex hormones. A T27C polymorphism (alleles A1 and A2, respectively) in the 5′ promoter region of CYP17 may be associated with elevated sex hormone levels. In a cross-sectional study of 181 pre- and 173 postmenopausal women, we examined the relationship of this polymorphism with mammographic density and other risk factors for breast cancer. Subjects were recruited across five categories of density. Risk factor and dietary information, anthropometric measures, and blood samples were obtained. Sex hormone, lipid, growth factor levels, and CYP17 genotypes were determined. CYP17 genotype was not associated with mammographic density levels before or after adjusting for risk factors for breast cancer. In premenopausal women, the A2 allele was associated with higher levels of dehydroepiandrosterone sulfate, and in postmenopausal women, with higher levels of total estradiol and lower levels of follicle stimulating hormone. Among premenopausal women, interactions were observed between CYP17 genotype and endogenous insulin levels as well as dietary variables associated with mammographic density. Our findings suggest that the CYP17 A2 allele is associated with hormone levels, and interacts with insulin levels and diet to affect breast density levels and potentially breast cancer risk.Keywords
This publication has 48 references indexed in Scilit:
- On Food Frequency QuestionnairesEpidemiology, 2004
- HSD17B1 and CYP17 polymorphisms and breast cancer risk among Chinese women in SingaporeInternational Journal of Cancer, 2003
- Relationship between serum hormone concentrations, reproductive history, alcohol consumption and genetic polymorphisms in pre‐menopausal womenInternational Journal of Cancer, 2002
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Effects of Weight Control and Physical Activity in Cancer PreventionAnnals of the New York Academy of Sciences, 2002
- Endogenous Sex Hormones and Breast Cancer in Postmenopausal Women: Reanalysis of Nine Prospective StudiesJNCI Journal of the National Cancer Institute, 2002
- Effects of Estrogen and Estrogen–Progestin on Mammographic Parenchymal DensityAnnals of Internal Medicine, 1999
- Circulating concentrations of insulin-like growth factor I and risk of breast cancerThe Lancet, 1998
- Effects of diet and exercise on insulin, sex hormone‐binding globulin, and prostate‐specific antigenNutrition and Cancer, 1998
- Decreases in Ovarian Cytochrome P450c17α Activity and Serum Free Testosterone after Reduction of Insulin Secretion in Polycystic Ovary SyndromeNew England Journal of Medicine, 1996